CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...